Kottiri B, Friedman SR, Neaigus A, Curtis R, Des Jarlais DC. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr
. 2002; 30: 95-104.CrossRefPubMed
Kral A, Bluthenthal RN, Watters JK. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health
. 1998; 88: 108-13.CrossRefPubMed
Schoenbaum E, Hartel D, Selwyn P. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med
. 1989; 321: 874-9.PubMed
Watters JK, Estilo M, Kral A, Lorvick JJ. HIV infection among female injection-drug users recruited in community settings. Sex Transm Dis
. 1994; 21: 321-8.PubMed
New attitudes & strategies: a comprehensive approach to preventing blood-borne infections among IDUs. CDC, 2000. http://www.cdc.gov/idu/idu.htm
. Accessed February 10, 2009.
Des Jarlais DC, McKnight C, Friedmann P. Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000–2001. J Am Pharm Assoc
. 2002; 42: S73-S6.CrossRef
Groseclose SL, Weinstein B, Jones TS, Valleroy LA, Fehrs L, Kassler WJ. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers—Connecticut, 1992–1993. J Acquir Immune Defic Syndr. 1995; 10: 82-9.
Valleroy LA, Weinstein B, Jones TS, Groseclose SL, Rolfs RT, Kassler WJ. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales—Connecticut, 1992–1993. J Acquir Immune Defic Syndr. 1995; 10: 73-81.
Deren S, Cleland CM, Fuller C, Kang S-Y, Des Jarlais DC, Vlahov D. The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings. AIDS Behav
. 2006; 10: 717-21.CrossRefPubMed
Cotten-Oldenburg N, Carr P, DeBoer J, Collison E, Novotny G. Impact of pharmacy-based syringe access on injection practices among injection drug users in Minnesota, 1998–1999. J Acquir Immune Defic Syndr
. 2001; 27: 183-92.PubMed
Singer M, Baer H, Scott G, Horowitz S, Weinstein B. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Reports
. 1998; 113: 81-9.PubMed
Fuller C, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings on injection drug users syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc
. 2002; 42: S77-S82.CrossRef
Fisher DG, Fenaughty AM, Cagle HH, Reynolds GL. Injection drug users' use of pharmacies for purchasing needles in Anchorage, Alaska. Int J Drug Policy
. 2003; 14: 381-7.CrossRef
Deren S, Fuller C, Pouget ER, et al. Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA. Int J Drug Policy
. 2003; 14: 373-9.CrossRef
Fuller C, Galea S, Blaney S, et al. Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethn Dis
. 2004; 14: 589-96.PubMed
Singer M, Himmelgreen D, Weeks M, Radda K, Martinez R. Changing the environment of AIDS risk: findings on syringe exchange and pharmacy sales of syringes in Hartford, CT. Med Anthropol
. 1997; 18: 107-30.PubMedCrossRef
Gostin L. The interconnected epidemics of drug dependency and AIDS. Harvard Civil Rights—Civil Liberties Law Review 1991; 26: 113–184.
Friedman SR, Perlis T, Des Jarlais DC. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health
. 2001; 91: 791-3.CrossRefPubMed
Des Jarlais DC, Hagan H, Friedman SR. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA
. 1996; 274: 1226-31.CrossRef
Romeis JBG, Northup T, Hager-Mace L, Friedman C, Des Jarlais DC. The Relationship between State Statutory Restrictions on Access to Syringes and AIDS Rates among Injecting Drug Users: Final Report. Jefferson City, Missouri: Missouri Department of Health, Bureau of AIDS Prevention; 1994.
Lurie P, Reingold A. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. San Francisco: School of Public Health at the University of California, Berkeley; 1993.
Burris S, Ng M. Deregulation of hypodermic needles and syringes as a public health measure: a report on emerging policy and law in the United States. George Mason University Civil Rights Law Journal. 2001; 12: 69–122.
Pouget ER, Deren S, Fuller C, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr
. 2005; 39: 471-7.CrossRefPubMed
Espinozw P, Bouchard I, Ballian F, Polo DeVoto J. Has the open sale of syringes modified the syringe exchange habit of drug addicts? Abstract presented at: 4th International Conference on AIDS. Stockholm; 1988.
Goldberg D, Watson HFS, Miller M, Gryer L, Follett E. Pharmacy supply of needles and syringes—the effect on spread of HIVamong intravenous drug misusers. Abstract presented at: 4th International Conference on AIDS. Stockholm; 1988.
Ingold F, Ingold S. The effects of the liberalization of syringe sales on the behavior of intravenous drug users in France. Bull Narc
. 1989; 41: 67-81.PubMed
Koester SK, Bush TW, Lewis BA. Limited access to syringes for injection drug users in pharmacies in Denver, Colorado. J Am Pharm Assoc
. 2002; 42: S88-S91.CrossRef
Finkelstein R, Tiger R, Greenwald R, Mukherjee R. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001–2002). J Am Pharm Assoc
. 2002; 42: S83-S7.CrossRef
Compton W, Cottler L, Decker S, Mager D, Stringfellow R. Legal needle buying in St. Louis. Am J Public Health
. 1992; 82: 595-6.CrossRefPubMed
Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2004; 61: 1026–44.
Bruneau J, Daniel M, Kestens Y, Zang G, Genereux M. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programs. J Epidemiol Community Health
. 2008; 62: 804-10.CrossRefPubMed
Rockwell R, Des Jarlais DC, Friedman SR, Perlis T, Paone D. Geographic proximity, policy, and utilization of syringe exchange programmes. AIDS Care
. 1999; 11: 437-42.CrossRefPubMed
Beardsley K, Wish E, Fitzelle D, O'Grady K, Arria A. Distance traveled to outpatient drug treatment and client retention. J Subst Abuse Treat
. 2003; 25: 279-85.CrossRefPubMed
Fortney J, Booth B, Blow F, Bunn J. The effects of travel barriers and age on the utilization of alcoholism treatment aftercare. Am J Drug Alcohol Abuse
. 1995; 21: 391-406.CrossRefPubMed
Hutchinson S, Taylor A, Goldberg D, Gruer L. Factors associated with injecting risk behavior among serial community-wide samples of injecting drug users in Glasgow 1990–1994: implications for control and prevention of blood-bourne viruses. Addiction
. 2000; 95: 931-40.CrossRefPubMed
Bonilla-Silva E. White Supremacy and Racism in the Post-Civil Rights Era. Boulder: Rienner; 2001.
Bluthenthal RN, Lorvick J, Kral AH, Erringer EA, Kahn JG. Collateral damage in the war on drugs: injection drug use. Int J Drug Policy
. 1999; 10: 25-38.CrossRef
Cooper H, Moore L, Gruskin S, Krieger N. The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: a qualitative study. Soc Sci Med
. 2005; 61: 673-84.CrossRefPubMed
Davis CS, Burris S, Kraut-Becher J, Lynch KG, Metzger D. Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA. Am J Public Health
. 2005; 95: 233-6.CrossRefPubMed
Friedman SR, Cooper HLF, Tempalski B, et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS
. 2006; 20: 93-9.CrossRefPubMed
Grund JP, Heckathorn D, Anthony D. In Eastern Connecticut, IDUs purchase syringes from pharmacies but don't carry syringes. JAIDS. 1995; 10: 105.
Koester SK. Copping, running, and paraphernalia laws: contextual variables and needle risk behavior among injection drug users in Denver. Human Organ. 1994; 53: 287-95.
Maher L, Dixon D. Policing and public health: law enforcement and harm reduction in a street-level drug market. Br J Criminol
. 1999; 39: 488-512.CrossRef
Philbin M, Pollini R, Ramos R, et al. Shooting gallery attendance among IDUs in Tijuana and Ciudad Juarez, Mexico: correlates, prevention opportunities, and the role of the environment. AIDS Behav
. 2008; 12: 552-60.CrossRefPubMed
Rhodes T, Mikhailova L, Sarang A, et al. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med
. 2003; 57: 39-54.CrossRefPubMed
Small W, Kerr T, Charette J, Schechter M, Spittal P. Impacts of intensified police activity on injection drug users: evidence from an ethnographic investigation. Int J Drug Policy
. 2006; 17: 85-95.CrossRef
Wood E, Kerr T, Small W, Jones J, Schechter M, Tyndall M. The impact of police presence on access to needle exchange programs. JAIDS
. 2003; 34: 116-8.PubMed
Friedman SR, Cooper H, Osbourne A. Structural and social contexts of HIV risk among African-Americans. Am J Public Health. 2009; 99: 1002-8.
Beckett K, Nyrop K, Pfingst L. Race, drugs, and policing: understanding disparities in drug delivery arrests. Criminology
. 2006; 44: 105-37.CrossRef
Cooper HLF, Wypij D, Krieger N. Police drug crackdowns and hospitalisation rates for illicit-injection-related infections in New York City. Int J Drug Policy
. 2005; 16: 150-60.CrossRef
Spernak SM, Mintz M, Paulson J, et al. Neighborhood racial composition and availability of asthma drugs in retail pharmacies. J Asthma
. 2005; 42: 731-5.CrossRefPubMed
Morrison RS, Wallenstein S, Natale D, Senzel RS, Huang L-L. “We don't carry that”—failure of pharmacies in predominatly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med
. 2000; 342: 1023-6.CrossRefPubMed
Pearson S-A, Soumerai S, Mah C, et al. Racial disparities in access after regulatory surveillance of benzodiazepines. Arch Inter Med
. 2006; 166: 572-9.CrossRef
Expanded Syringe Access Program (ESAP): overview of the law and regulations. NYSDOH, 2008. http://www.health.state.ny.us/diseases/aids/harm_reduction/needles_syringes/esap/overview.htm
. Accessed January 7, 2009.
The New York State AIDS Advisory Council. Report on Syringe Access in New York State. New York: NYSDOH; 2005.
United Hospital Fund. UHF Health Atlas. New York City: United Hospital Fund; 2005.
New York City Department of Health and Mental Hygiene. City Wide Community Health Profile. New York: NYCDOH; 2001.
New York City Department of Health and Mental Hygiene, 2006. New York City Community Health Profiles. Accessed at http://www.nyc.gov/html/doh/html/data/data.shtml
on September 15, 2009.
Guargliardo M, Ronzio C, Cheung I, Chacko E, Joseph J. Physcian accessibility: an urban case study of pediatric providers. Health and Place. 2004; 10: 273–83.
Luo W. Using a GIS-based floating catchment method to assess areas with shortage of physicians. Health Place
. 2004; 10: 1-11.CrossRefPubMed
Luo W, Wang F. Measures of spatial accessibility of health care in a GIS environment: synthesis and a case study in the Chicago region. Environ Plann B Plann Des
. 2003; 30: 865-84.CrossRef
Takahashi L. Homelessness, AIDS, and stigmatization. Oxford: Clarendon; 1998.
Tempalski B, Friedman R, Keem M, Cooper H, Friedman SR. NIMBY localism and national inequitable exclusion alliances: the case of syringe exchange programs in the United States. Geoforum
. 2007; 38: 1250-63.CrossRefPubMed
Khan A. An integrated approach to measuring potential spatial access to health care services. Socioecon Plann Sci
. 1992; 26: 275-87.CrossRefPubMed
Joseph A, Phillips D. Accessibility and Utilization: Geographical Perspectives on Health Care Delivery. New York: Harper and Row; 1984.
Phillips D. Health and Health Care in the Third World. Essex: Longman Scientific and Technical; 1990.
Thouez J, Bodson P, Joseph A. Some methods for measuring the geographic accessibility of medical service in rural regions. Med Care
. 1988; 26: 34-44.CrossRefPubMed
Bailey T, Gastrell A. Interactive Spatial Data Analysis. Essex: Longman Scientific and Technical; 1995.
Cromley E, McClafferty S. GIS and Public Health. New York: Guilford; 2002.
Lawson A. Statistical Methods in Spatial Epidemiology. New York: Wiley; 2001.
Krieger N, Waterman P, Lemieux K, Zierler S, Hogan J. On the wrong side of the tracts? Evaluating the accuracy of geocoding in public health research. Am J Public Health
. 2001; 91: 1114-6.CrossRefPubMed
McClafferty S, Grady S. Prenatal care need and access: a GIS analysis. J Med Syst
. 2004; 28: 321-33.CrossRef
McClafferty S, Grady S. Immigration and geographic access to prenatal clinics in Brooklyn, NY: a geographic information systems analysis. Am J Public Health
. 2005; 95: 638-40.CrossRef
Wang F. Quantitative Methods in Applications in GIS. New York: Taylor and Francis; 2006.
PRISMS Prevention Risk Indicator Services Monitoring System. OASAS, 2009. http://www.oasas.state.ny.us/hps/datamart/prisms_home.cfm
Hartwig F, Dearing B. Exploratory Data Analysis. Newbury Park: Sage; 1979.
Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York: Oxford University Press; 2003.
Bauer DJ, Curran PJ. Probing interactions in fixed and multilevel regression: inferential and graphical techniques. Multivariate Behav Res
. 2005; 40: 373-400.CrossRef
Preacher C, Curran PJ, Bauer DJ. Computational tools for probing interaction effects in multiple linear regression, multilevel modeling, and latent curve analysis. J Educ Behav Stat
. 2006; 31: 437-48.CrossRef
Jaccard J, Turrisi R. Interaction Effects in Multiple Regression. 2nd ed. Thousand Oaks: Sage; 2003.
ESRI. ArcInfo software program version 9.2. In; 2006.
SAS Institute I. SAS/STAT 9.2. In. Cary, NC: SAS Institute; 2008.
New York City Department of Health and Mental Hygiene. Community Health Profiles: Stapleton and St. George. New York City: NYCDOHMH; 2006.
Tempalski B, Flom PL, Friedman SR, et al. Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas. Am J Public Health
. 2007; 97: 437-47.CrossRefPubMed
Friedman SR, Tempalski B, Brady JE, et al. Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America. Int J Drug Policy
. 2007; 18: 475-85.CrossRefPubMed
Bluthenthal RN, Kral AH, Lorvick J, Watters JK. Impact of law enforcement on syringe exchange prorgams: a look at Oakland and San Francisco. Med Anthropol
. 1997; 18: 61-83.PubMedCrossRef
Rich J, Strong L, Towe C, McKenzie M. Obstacles to needle exchange participation in Rhode Island. J Acquir Immune Defic Syndr
. 1999; 21: 396-400.CrossRefPubMed
General Update on the Expanded Syringe Access Program (ESAP). NYSDOH, 2008. Accessed on March 16, 2009 and available at http://www.health.state.ny.us/diseases/aids/harm_reduction/needles_syringes/esap/update.htm
Fuller C, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health
. 2007; 97: 117-24.CrossRefPubMed
Reich W, Compton W, Horton JC, et al. Injection Drug Users Report Good Access to Pharmacy Sale of Syringes. J Am Pharm Assoc
. 2002; 42: S68-S72.CrossRef